Ingenza

Ingenza is a technology-driven CRDMO founded in 2002, offering end-to-end services from strain/cell-line engineering to bioprocess development. Its core strength is the proprietary 'in Genius' platform, which integrates AI/ML tools like codABLE® with microbial and mammalian systems to accelerate and de-risk client projects. With a strong track record in yield enhancement and a diverse client base across pharma and sustainable biotech, the company is positioned for aggressive growth under new leadership with deep industry experience.

The 'in Genius' platform integrates proprietary host engineering (microbial/mammalian), AI/ML design tool codABLE®, and bioprocess development for accelerated, de-risked protein and molecule production.

Ingenza competes with other synthetic biology service providers and CRDMOs, ranging from large CROs/CDMOs like Lonza and Sartorius to specialized platform companies such as Ginkgo Bioworks and Codexis. Its differentiation lies in its integrated 'full-service' approach, proprietary AI tool (codABLE®), and strong track record in yield enhancement.